DIZAL PHARMACEUTICAL
Samsung Electronics denies report that it is exploring US listingSamsung Electronics denied exploring a U.S. listing of American Depositary Receipts. Bloomberg News had reported preliminary discussions wi...
AstraZeneca to license lung cancer drug from China's Dizal PharmaceuticalDizal Pharmaceutical shares rose significantly after announcing a major drug rights deal. AstraZeneca will pay $600 million upfront for glo...
- Load More